These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 12711119

  • 1. A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery.
    Endo C, Saito Y, Iwanami H, Tsushima T, Imai T, Kawamura M, Kondo T, Koike K, Handa M, Kanno R, Fujimura S, North-east Japan Study Group for Lung Cancer Surgery.
    Lung Cancer; 2003 May; 40(2):181-6. PubMed ID: 12711119
    [Abstract] [Full Text] [Related]

  • 2. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F, Miyahara R, Ohtake Y, Yanagihara K, Fukuse T, Hitomi S, Wada H.
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [Abstract] [Full Text] [Related]

  • 3. A small randomized phase III single-center trial on postoperative UFT administration in patients with completely resected non-small cell lung cancer.
    Ueda H, Sakada T, Kuwahara M, Motohiro A.
    Anticancer Drugs; 2004 Jan; 15(1):29-33. PubMed ID: 15090740
    [Abstract] [Full Text] [Related]

  • 4. Postoperative adjuvant chemotherapy for non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. The Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy.
    Wada H, Tanaka F, Hitomi S.
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):98-102. PubMed ID: 9348578
    [Abstract] [Full Text] [Related]

  • 5. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
    Wada H, Miyahara R, Tanaka F, Hitomi S.
    Eur J Cardiothorac Surg; 1999 Apr; 15(4):438-43. PubMed ID: 10371118
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
    Wada H, Hitomi S, Teramatsu T.
    J Clin Oncol; 1996 Apr; 14(4):1048-54. PubMed ID: 8648356
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
    Nakagawa T, Tanaka F, Takata T, Matsuoka K, Miyahara R, Otake Y, Yanagihara K, Fukushimab M, Wada H.
    J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
    [Abstract] [Full Text] [Related]

  • 8. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M, Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [Abstract] [Full Text] [Related]

  • 9. A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG)--the 4th study.
    Nakagawa M, Tanaka F, Tsubota N, Ohta M, Takao M, Wada H, West Japan Study Group for Lung Cancer Surgery.
    Ann Oncol; 2005 Jan; 16(1):75-80. PubMed ID: 15598942
    [Abstract] [Full Text] [Related]

  • 10. Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials.
    Hamada C, Tsuboi M, Ohta M, Fujimura S, Kodama K, Imaizumi M, Wada H.
    J Thorac Oncol; 2009 Dec; 4(12):1511-6. PubMed ID: 19875974
    [Abstract] [Full Text] [Related]

  • 11. A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer.
    Toyooka S, Okumura N, Nakamura H, Nakata M, Yamashita M, Tada H, Kajiwara S, Watanabe N, Okada M, Sakamoto J, Aoe M, Soh J, Miyoshi S, Hotta K, Matsuo K, Date H.
    J Thorac Oncol; 2018 May; 13(5):699-706. PubMed ID: 29505900
    [Abstract] [Full Text] [Related]

  • 12. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
    Hamada C, Tanaka F, Ohta M, Fujimura S, Kodama K, Imaizumi M, Wada H.
    J Clin Oncol; 2005 Aug 01; 23(22):4999-5006. PubMed ID: 16051951
    [Abstract] [Full Text] [Related]

  • 13. Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer.
    Tanaka F, Yanagihara K, Otake Y, Miyahara R, Wada H.
    Cancer Sci; 2004 Apr 01; 95(4):371-6. PubMed ID: 15072598
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
    Eur J Surg Oncol; 1995 Feb 01; 21(1):69-77. PubMed ID: 7851558
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
    Suehisa H, Toyooka S.
    Acta Med Okayama; 2009 Oct 01; 63(5):223-30. PubMed ID: 19893597
    [Abstract] [Full Text] [Related]

  • 16. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.
    Tsuchiya T, Kamohara R, Muraoka M, Nagayasu T, Saeki S, Takenoyama M, Suzuki M, Inada K, Tokunaga S, Hayashi T, Urabe S, Koga T, Akamine S, Sugio K.
    BMC Cancer; 2020 Dec 04; 20(1):1192. PubMed ID: 33276755
    [Abstract] [Full Text] [Related]

  • 17. Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer.
    Nakagawa K, Tada H, Akashi A, Yasumitsu T, Iuchi K, Taki T, Kodama K, Osaka Lung Cancer Study Group, Japan.
    Br J Cancer; 2006 Oct 09; 95(7):817-21. PubMed ID: 16969350
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
    Liang SK, Wu CW, Chang CI, Keng LT, Lee MR, Wang JY, Ko JC, Liao WY, Chen KY, Ho CC, Shih JY, Yu CJ.
    Cancer Med; 2023 Sep 09; 12(17):17993-18004. PubMed ID: 37559409
    [Abstract] [Full Text] [Related]

  • 20. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
    Matsuda C, Ishiguro M, Teramukai S, Kajiwara Y, Fujii S, Kinugasa Y, Nakamoto Y, Kotake M, Sakamoto Y, Kurachi K, Maeda A, Komori K, Tomita N, Shimada Y, Takahashi K, Kotake K, Watanabe M, Mochizuki H, Nakagawa Y, Sugihara K, SACURA Study Group.
    Eur J Cancer; 2018 Jun 09; 96():54-63. PubMed ID: 29677641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.